
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc is strategically positioned to leverage the anticipated favorable 2026 rate update, especially as many managed care organizations are reducing benefits, granting ALHC a competitive edge through its Stars funding advantage. The company's integrated Medicare Advantage value-based care model is expected to foster long-term market share gains and above-average growth, supported by promising gross profit per member per month metrics projected to improve from $90-$150 in the first two years to over $230 in years three to five. Additionally, the stronger-than-expected 2026 MA rate update may enhance membership growth and improve cohort margin maturation, further contributing to the company's positive financial outlook.
Bears say
Alignment Healthcare Inc faces challenges that contribute to a negative outlook, primarily due to data friction across different payors and inconsistent outcomes from employed or affiliated primary care providers (PCPs). While the company has reported lower average daily costs (ADK) amidst increased healthcare utilization, the implications of the rising costs and complexities related to the Medicare Advantage market can strain financial performance. Additionally, despite the company’s above-average EBITDA growth relative to peers, its valuation multiple remains slightly elevated, suggesting that potential risks may not be fully reflected in the stock price.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares